Heartflow is a company that's using AI to help detect and eventually treat heart disease, which is the leading cause of death - higher than cancer. You would think that means there's a large total addressable market here, but you might be surprised. Today, we'll look at this upcoming AI IPO and decide if we should keep an eye on it for our disruptive technology portfolio.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/x-2ywfk7v2w.